A phase 1 trial of copanlisib plus ibrutinib in relapsed/refractory mantle cell lymphoma

Detalles Bibliográficos
Autores principales: Qualls, David, Lam, Hiu Ying, Whiting, Karissa, Kumar, Anita, Matasar, Matthew, Owens, Colette, Nichols, Chelsea, Espeleta, James A, Qiu, Annie, Subzwari, Sarima, Biggar, Erin, Seshan, Venkatraman, Salles, Gilles, Younes, Anas, Batlevi, Connie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631700/
https://www.ncbi.nlm.nih.gov/pubmed/35171976
http://dx.doi.org/10.1182/bloodadvances.2021006555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631700/
https://www.ncbi.nlm.nih.gov/pubmed/35171976
http://dx.doi.org/10.1182/bloodadvances.2021006555

Ejemplares similares